Amelia Insa Selected Research

Amelia Insa Research Topics

Disease

27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 05/2004
8	Neoplasms (Cancer) 01/2022 - 03/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2007
4	Disease Progression 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 04/2009 - 03/2006
1	Adenocarcinoma of Lung 12/2021
1	Teratocarcinoma 01/2021
1	Diarrhea 12/2020
1	Oncogene Addiction 12/2020
1	Fatigue 12/2020
1	Anemia 12/2020
1	Febrile Neutropenia 11/2020
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2017
1	Exanthema (Rash) 03/2012
1	Neutropenia 03/2012
1	Hypersensitivity (Allergy) 09/2009

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 12/2021 - 09/2009
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 09/2009
4	NivolumabIBA 08/2023 - 11/2020
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2021
3	Docetaxel (Taxotere)FDA Link 12/2021 - 01/2017
3	Gefitinib (Iressa)FDA Link 12/2020 - 09/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 05/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 11/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021 - 01/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2014
2	Gemcitabine FDA Link 01/2017 - 05/2004
1	atezolizumabIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Interferon Type IIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	veliparibIBA 01/2022
1	nintedanibIBA 12/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	olaparibIBA 12/2020
1	Lipase (Acid Lipase)FDA Link 11/2020
1	osimertinibIBA 07/2020
1	Chemokine ReceptorsIBA 01/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	CrizotinibIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	PlatinumIBA 01/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	AfatinibIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 05/2015
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	Vorinostat FDA Link 05/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	dalotuzumabIBA 01/2014
1	TransferasesIBA 03/2012
1	Messenger RNA (mRNA)IBA 03/2011
1	AnthracyclinesIBA 04/2009
1	taxaneIBA 04/2009
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 05/2004
1	HomocysteineIBA 05/2004

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 08/2023 - 03/2006
4	Neoadjuvant Therapy 01/2022 - 03/2006
3	Immunotherapy 01/2022 - 01/2021
3	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2021
2	Therapeutics 01/2022 - 03/2006
2	Induction Chemotherapy 01/2017 - 10/2007
1	Aftercare (After-Treatment) 01/2022